Penn Mutual Asset Management’s Phathom Pharmaceuticals PHAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$681K Hold
62,802
3.5% 5
2026
Q1
$698K Hold
62,802
3.57% 6
2025
Q4
$1.04M Hold
62,802
0.62% 8
2025
Q3
$739K Hold
62,802
1.44% 18
2025
Q2
$602K Hold
62,802
1.06% 23
2025
Q1
$394K Hold
62,802
0.76% 39
2024
Q4
$510K Hold
62,802
0.92% 30
2024
Q3
$1.14M Hold
62,802
2.25% 9
2024
Q2
$647K Hold
62,802
1.38% 11
2024
Q1
$667K Hold
62,802
1.42% 13
2023
Q4
$573K Hold
62,802
0.44% 50
2023
Q3
$651K Hold
62,802
0.61% 45
2023
Q2
$899K Hold
62,802
0.81% 42
2023
Q1
$448K Hold
62,802
0.43% 46
2022
Q4
$705K Sell
62,802
-24,138
-28% -$249K 0.79% 37
2022
Q3
$963K Hold
86,940
1.26% 29
2022
Q2
$734K Hold
86,940
0.99% 30
2022
Q1
$1.18M Buy
+86,940
New +$1.4M 1.37% 18
2021
Q4
Sell
-86,940
Closed -$2.79M 68
2021
Q3
$2.79M Hold
86,940
4.41% 7
2021
Q2
$2.94M Hold
86,940
3.68% 8
2021
Q1
$3.27M Hold
86,940
3.69% 10
2020
Q4
$2.89M Hold
86,940
2.55% 12
2020
Q3
$3.19M Hold
86,940
4.5% 10
2020
Q2
$2.86M Buy
+86,940
New +$3.34M 2.92% 13

Other funds holding PHAT

Penn Mutual Asset Management's PHAT Position: Q2 2026 in Review

Penn Mutual Asset Management held its Phathom Pharmaceuticals (PHAT) position steady in Q2 2026 at 62,802 shares worth $681K. The position accounts for 3.5% of the portfolio, ranked #5.

Penn Mutual Asset Management first reported a position in PHAT in Q2 2020 and has held it in 24 quarters since. The position peaked at $3.27M in Q1 2021. 16 funds tracked by Wall St. Rank hold PHAT as of Q2 2026.

  • Penn Mutual Asset Management held 62,802 shares of Phathom Pharmaceuticals worth $681K as of Q2 2026.
  • Penn Mutual Asset Management left its Phathom Pharmaceuticals share count unchanged in Q2 2026.
  • Phathom Pharmaceuticals made up 3.5% of Penn Mutual Asset Management's portfolio in Q2 2026, its #5 holding.
  • Penn Mutual Asset Management first reported a position in Phathom Pharmaceuticals in Q2 2020 and has held it in 24 quarters since.
  • Penn Mutual Asset Management's Phathom Pharmaceuticals position peaked at $3.27M in Q1 2021.
  • 16 funds tracked by Wall St. Rank held Phathom Pharmaceuticals as of Q2 2026.

Based on Penn Mutual Asset Management's 13F filing for Q2 2026, filed 24 Jul 2026.